Showing results (741-750 of 2,753) with videos related to

Sort By:
Pageof 276
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Neoplasia (New York, N.Y.)|November 16, 2010
Phase 1/2 study of atrasentan combined with pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancerPetronella O Witteveen, Koen J C van der Mijn, Maartje Los, et al.
Neoplasia (New York, N.Y.)|November 16, 2010
Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activationGeetha Rao, Dingxie Liu, Mingzhao Xing, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistanceKimmo J Hatanpaa, Sandeep Burma, Dawen Zhao, et al.
Neoplasia (New York, N.Y.)|September 9, 2010
Somatic expression of PyMT or activated ErbB2 induces estrogen-independent mammary tumorigenesisMichael J Toneff, Zhijun Du, Jie Dong, et al.
Neoplasia (New York, N.Y.)|October 8, 2010
A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathwayTakahiro Wakasaki, Muneyuki Masuda, Hiroaki Niiro, et al.
Neoplasia (New York, N.Y.)|October 8, 2010
Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancerBirgit Hotz, Marina V Backer, Joseph M Backer, et al.
Neoplasia (New York, N.Y.)|December 21, 2010
NHERF1/EBP50 is a new marker in colorectal cancerYuho Hayashi, Jennifer R Molina, Stanley R Hamilton, et al.
Neoplasia (New York, N.Y.)|January 20, 2011
Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancerN Patrick McCabe, Bethany A Kerr, Maria Madajka, et al.
Neoplasia (New York, N.Y.)|January 20, 2011
Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma modelsInga J Duignan, Erik Corcoran, Anthony Pennello, et al.
Pageof 276